Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Recruiting · NCT05686447 · Registry updated 2025-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis | Blood Protein Disorders, Gammopathy, Monoclonal, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2025-04-06 | NCT05686447 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Natural Science Foundation of China | 35 |
| Zhujiang Hospital | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 17 |